High materiality8/10
H.C. Wainwright Reiterates Buy Rating on Crescent Biopharma Inc (CBIO)
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS target update; Target 36; current price 11.86; price change +2.26 since signal.
- Target 36; price 11.86; +2.26 since signal
- UBS target update
Key facts
- 01
Target: $36
- 02
Posted price: $11.86
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.